Salvatore Alesci
Corporate Officer/Principal chez TAKEDA PHARMACEUTICAL COMPANY LIMITED
Postes actifs de Salvatore Alesci
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - | - |
Invea Therapeutics, Inc.
 Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Directeur Technique/Scientifique/R&D | 01/01/2022 | - |
Historique de carrière de Salvatore Alesci
Statistiques
Internationale
| Japon | 2 |
| Etats-Unis | 2 |
Opérationnelle
| Corporate Officer/Principal | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Health Technology |
- Bourse
- Insiders
- Salvatore Alesci
- Expérience
